Phase
Condition
Holoprosencephaly
Neuronal Ceroid Lipofuscinoses (Ncl)
Treatment
newborn genetic screening and whole genome sequencing
Clinical Study ID
Ages < 2 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
TREAT-panel:
newborns
Infants born in one of the participating hospitals and birth centres
Informed consent signed by both parents/legal guardian to participate ingenetic newborn screening (TREAT-panel)
Whole genome sequencing:
Participation in the TREAT-panel study
Symptoms suggestive of a genetic disease within the first 2 years of life
Informed consent signed by both parents/legal guardian to participate ingenetic newborn screening (TREAT-panel) and the whole genome sequencing
Exclusion
Exclusion Criteria:
- Missing informed consent of parents/legal guardian
Study Design
Connect with a study center
Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital d'Enfants
Dijon, 21079
FranceActive - Recruiting
Clinic for Neuropediatrics and Muscular Diseases, Freiburg University Medical Center
Freiburg, 79106
GermanyActive - Recruiting
Ospedale Pediatrivo Bambino Gesu IRCCS
Rome, Lazio 00165
ItalyActive - Recruiting
Unit Medical Genetics, Azienda Ospedaliero-Universitaria Sant'Anna
Ferrara, 44122
ItalyActive - Recruiting
Azienda Ospedaliero Universitaria di Modena, Neonatology Unit
Modena, 41100
ItalyActive - Recruiting
San Pietro Fatebenefratelli Hospital
Roma, 00189
ItalyActive - Recruiting
Università degli Studi Di Siena
Siena, 53100
ItalySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.